180 related articles for article (PubMed ID: 19193441)
1. In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R.
Sirven P; Castelli FA; Probst A; Szely N; Maillere B
Mol Immunol; 2009 Apr; 46(7):1481-7. PubMed ID: 19193441
[TBL] [Abstract][Full Text] [Related]
2. Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively.
Castelli FA; Houitte D; Munier G; Szely N; Lecoq A; Briand JP; Muller S; Maillere B
Eur J Immunol; 2008 Oct; 38(10):2821-31. PubMed ID: 18828138
[TBL] [Abstract][Full Text] [Related]
3. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.
Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012
[TBL] [Abstract][Full Text] [Related]
8. The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.
Cecconi V; Moro M; Del Mare S; Sidney J; Bachi A; Longhi R; Sette A; Protti MP; Dellabona P; Casorati G
Eur J Immunol; 2010 Jun; 40(6):1603-16. PubMed ID: 20306469
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
[TBL] [Abstract][Full Text] [Related]
11. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.
Serangeli C; Bicanic O; Scheible MH; Wernet D; Lang P; Rammensee HG; Stevanovic S; Handgretinger R; Feuchtinger T
Virology; 2010 Feb; 397(2):277-84. PubMed ID: 19962170
[TBL] [Abstract][Full Text] [Related]
13. Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules.
van der Burg SH; Kwappenberg KM; Geluk A; van der Kruk M; Pontesilli O; Hovenkamp E; Franken KL; van Meijgaarden KE; Drijfhout JW; Ottenhoff TH; Melief CJ; Offringa R
J Immunol; 1999 Jan; 162(1):152-60. PubMed ID: 9886381
[TBL] [Abstract][Full Text] [Related]
14. Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors.
Castelli FA; Szely N; Olivain A; Casartelli N; Grygar C; Schneider A; Besse A; Levy Y; Schwartz O; Maillère B
J Immunol; 2013 Jun; 190(11):5757-63. PubMed ID: 23636059
[TBL] [Abstract][Full Text] [Related]
15. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
[TBL] [Abstract][Full Text] [Related]
17. T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG.
Hestvik AL; Vartdal F; Fredriksen AB; Thompson KM; Kvale EO; Skorstad G; Bogen B; Holmoy T
Scand J Immunol; 2007 Oct; 66(4):393-401. PubMed ID: 17850583
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
[TBL] [Abstract][Full Text] [Related]
19. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis.
Mustafa AS
Scand J Immunol; 2009 Mar; 69(3):213-22. PubMed ID: 19281533
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes.
Facchinetti V; Seresini S; Longhi R; Garavaglia C; Casorati G; Protti MP
Eur J Immunol; 2005 Mar; 35(3):806-15. PubMed ID: 15719368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
